Ignite Creation Date:
2025-12-18 @ 9:07 AM
Ignite Modification Date:
2025-12-23 @ 6:43 PM
Study NCT ID:
NCT00826449
Status:
None
Last Update Posted:
2016-06-28 00:00:00
First Post:
2009-01-20 00:00:00
Is Possible Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
Dasatinib and Erlotinib in Non-Small Cell Lung Cancer (NSCLC)
Sponsor:
None
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2009-02
Start Date Type:
None
Primary Completion Date:
2014-06
Primary Completion Date Type:
ACTUAL
Completion Date:
2014-06
Completion Date Type:
ACTUAL
First Submit Date:
2009-01-20 00:00:00
First Submit QC Date:
None
Study First Post Date:
2009-01-22
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2015-09-18 00:00:00
Results First Submit QC Date:
None
Results First Post Date:
2015-10-21
Results First Post Date Type:
ESTIMATED
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2016-05-26 00:00:00
Last Update Post Date:
2016-06-28 00:00:00
Last Update Post Date Type:
ESTIMATED